Tonix Pharmaceuticals Holding (TNXP) Other Operating Expenses (2019 - 2026)

Tonix Pharmaceuticals Holding's Other Operating Expenses history runs 5 years deep, the most recent figure standing at $1.6 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 67.34% year-over-year to $1.6 million in Q1 2026; TTM through Mar 2026 was $7.3 million, a 88.98% decrease from a year earlier, with the FY2025 full-year figure at $6.6 million, down 90.05% from the prior year.
• Other Operating Expenses rose to $1.6 million in Q1 2026 per TNXP's latest filing, from $1.1 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $62.3 million in Q2 2024 and bottomed at $943000.0 in Q1 2025.
• The 4-year median for Other Operating Expenses is $1.6 million (2026), against an average of $7.2 million.
• Across the five-year window, Other Operating Expenses sank 94.75% in 2025 and surged 67.34% in 2026, its largest moves.
• Year by year, Other Operating Expenses stood at $2.4 million in 2023, then tumbled by 50.02% to $1.2 million in 2024, then dropped by 10.57% to $1.1 million in 2025, then soared by 49.15% to $1.6 million in 2026.
• Per Business Quant, the three latest TNXP Other Operating Expenses figures stand at $1.6 million (Q1 2026), $1.1 million (Q4 2025), and $1.4 million (Q3 2025).